Frontlight ResearchEarly access
Trial site
Dr. Vehling-Kaiser MVZ GmbH
- 13running trials
- 6closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer6 trials
- Chronic lymphocytic leukaemia3 trials
- Lung cancer2 trials
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Hodgkin lymphoma1 trial
- Mantle cell lymphoma1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 311 trials
- Phase 28 trials
- Phase 41 trial
- Status
- Recruiting7 trials
- Completed6 trials
- Active, not recruiting5 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Dominik Paul Modest3 trials
- Christian Buske2 trials
- Merck Sharp & Dohme LLC2 trials
- University Of Cologne2 trials
- AbbVie1 trial
- and 10 more
Running trials
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia
Active, not recruiting
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer4 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- Lung cancer1 recruiting
Closed trials
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026